Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
99.6M
-
Number of holders
-
410
-
Total 13F shares, excl. options
-
89.7M
-
Shares change
-
-1.33M
-
Total reported value, excl. options
-
$8.63B
-
Value change
-
-$165M
-
Put/Call ratio
-
2.32
-
Number of buys
-
246
-
Number of sells
-
-171
-
Price
-
$96.16
Significant Holders of NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) as of Q3 2020
503 filings reported holding NBIX - NEUROCRINE BIOSCIENCES INC - Common Stock as of Q3 2020.
NEUROCRINE BIOSCIENCES INC - Common Stock (NBIX) has 410 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 89.7M shares
of 99.6M outstanding shares and own 90.07% of the company stock.
Largest 10 shareholders include FMR LLC (8.7M shares), VANGUARD GROUP INC (8.16M shares), BlackRock Inc. (6.81M shares), JANUS HENDERSON GROUP PLC (6.55M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.42M shares), Capital International Investors (4.28M shares), Bellevue Group AG (3.3M shares), STATE STREET CORP (2.28M shares), RENAISSANCE TECHNOLOGIES LLC (2.15M shares), and Invesco Ltd. (1.73M shares).
This table shows the top 410 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.